The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure.

Changes in health policy have underlined the importance of evidence-based clinical practice and rigorous evaluation of patient-based outcomes. As patient-based outcome measurement is particularly important in treatment trials of multiple sclerosis, a number of disease-specific instruments have been developed recently. One limitation of these instruments is that none was developed using the standard psychometric approach of reducing a large item pool generated from people with multiple sclerosis. Consequently, an outcome measure for clinical trials of multiple sclerosis that is disease specific and combines patient perspective with rigorous psychometric methods will complement existing instruments. The aim of this study was to develop such a measure. Standard psychometric methods were used. A pool of 129 questionnaire items was generated from interviews with 30 people with multiple sclerosis, expert opinion and literature review. The questionnaire was administered by postal survey to 1530 people selected randomly from the Multiple Sclerosis Society membership database. Redundant items and those with limited measurement properties were removed. The remaining items (n = 41) were grouped into scales using factor analysis, and then refined to form the Multiple Sclerosis Impact Scale (MSIS-29), an instrument measuring the physical (20 items) and psychological (nine items) impact of multiple sclerosis. Five psychometric properties of the MSIS-29 (data quality, scaling assumptions, acceptability, reliability and validity) were examined in a separate postal survey of 1250 Multiple Sclerosis Society members. A preliminary responsiveness study of the MSIS-29 was undertaken in 55 people admitted for rehabilitation and intravenous steroid treatment of relapses. The MSIS-29 satisfied all psychometric criteria. Data quality was excellent, missing data were low (maximum 3.9%), item test-re-test reliability was high (r = 0.65-0.90) and scale scores could be generated for >98% of respondents. Item descriptive statistics, item convergent and discriminant validity, and factor analysis indicated that it was legitimate to generate scores for MSIS-29 scales by summing items. MSIS-29 scales showed good variability, small floor and ceiling effects, high internal consistency (Cronbach's alpha <or=0.91) and high test-re-test reliability (intraclass correlation <or=0.87). Correlations with other measures and the analysis of group differences provided evidence that the MSIS-29 measures the physical and psychological impact of multiple sclerosis. Effect sizes (physical scale = 0.82, psychological scale = 0.66) demonstrated preliminary evidence of good responsiveness. These results indicate the MSIS-29 is a clinically useful and scientifically sound patient-based outcome measure of the impact of multiple sclerosis suitable for clinical trials and epidemiological studies.

[1]  M. R. Novick,et al.  Statistical Theories of Mental Test Scores. , 1971 .

[2]  G. Guyatt,et al.  Clinical impact versus factor analysis for quality of life questionnaire construction. , 1997, Journal of clinical epidemiology.

[3]  T Riise,et al.  Performance of the SF-36, SF-12, and RAND-36 Summary Scales in a Multiple Sclerosis Population , 2000, Medical care.

[4]  B. Sharrack,et al.  The psychometric properties of clinical rating scales used in multiple sclerosis. , 1999, Brain : a journal of neurology.

[5]  J. Ware.  SF-36 health survey: Manual and interpretation guide , 2003 .

[6]  C. Polman,et al.  A health‐related quality of life questionnaire for multiple sclerosis Patients , 1999, Acta neurologica Scandinavica.

[7]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[8]  Lewis E. Kazis,et al.  Effect Sizes for Interpreting Changes in Health Status , 1989, Medical care.

[9]  J. Bartko.  The Intraclass Correlation Coefficient as a Measure of Reliability , 1966, Psychological reports.

[10]  G. Karabatsos,et al.  Validation of the Functional Assessment of Multiple Sclerosis quality of life instrument , 1996, Neurology.

[11]  B. Gandek,et al.  MAP-R for windows: multitrait / multi-item analysis program - revised user's guide. , 1997 .

[12]  Stephen M. Rao,et al.  Development of a multiple sclerosis functional composite as a clinical trial outcome measure. , 1999, Brain : a journal of neurology.

[13]  J. Fleiss.  The design and analysis of clinical experiments , 1987 .

[14]  Deborah M. Miller,et al.  “Quality of Life” Assessment in Multiple Sclerosis Clinical Trials: Current Status and Strategies for Improving Multiple Sclerosis Clinical Trial Design , 1996 .

[15]  Jacob Cohen.  Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.

[16]  J. Shea,et al.  SF-20 score and item distributions in a human immunodeficiency virus-seropositive sample. , 1996, Medical care.

[17]  Ron D. Hays,et al.  Quality of life assessment in clinical trials : methods and practice , 1998 .

[18]  J. Ware,et al.  Conceptualization and Measurement of Health for Adults in the Health Insurance Study , 1979 .

[19]  A. Williams.  EuroQol : a new facility for the measurement of health-related quality of life , 1990 .

[20]  M J Buxton,et al.  Evaluating patient-based outcome measures for use in clinical trials. , 1998, Health technology assessment.

[21]  A. Stewart,et al.  Measuring Functioning and Well-Being: The Medical Outcomes Study Approach , 1992 .

[22]  R. Deyo,et al.  Generic and Disease-Specific Measures in Assessing Health Status and Quality of Life , 1989, Medical care.

[23]  L. Guttman.  Some necessary conditions for common-factor analysis , 1954 .

[24]  A. Thompson,et al.  Clinical appropriateness: a key factor in outcome measure selection: the 36 item short form health survey in multiple sclerosis , 2000, Journal of neurology, neurosurgery, and psychiatry.

[25]  K N Lohr,et al.  Evaluating quality-of-life and health status instruments: development of scientific review criteria. , 1996, Clinical therapeutics.

[26]  R. Rudick,et al.  Multiple sclerosis : advances in clinical trial design, treatment, and future perspectives , 1996 .

[27]  C. Sherbourne,et al.  The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. , 1994 .

[28]  D. Streiner,et al.  Health Measurement Scales: A practical guide to thier development and use , 1989 .

[29]  John E. Ware,et al.  SF-36 physical and mental health summary scales : a user's manual , 1994 .

[30]  Christian Confavreux,et al.  Recommendations from the national multiple sclerosis society clinical outcomes assessment task force , 1997, Annals of neurology.

[31]  J Fermanian,et al.  Development and validation of a rheumatoid hand functional disability scale that assesses functional handicap. , 1996, The Journal of rheumatology.

[32]  C Jenkinson,et al.  Development Standards for Health Measures , 1996, Journal of health services research & policy.

[33]  R. Cattell.  The Scree Test For The Number Of Factors. , 1966, Multivariate behavioral research.

[34]  S. Saxena,et al.  The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties. , 1998, Social science & medicine.

[35]  B. Sharrack,et al.  The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis , 1999, Multiple sclerosis.

[36]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[37]  Shah Ebrahim,et al.  A postal version of the Barthel Index , 1994 .

[38]  James D. Wright,et al.  Handbook of Survey Research. , 1985 .

[39]  L. Cronbach,et al.  Construct validity in psychological tests. , 1955, Psychological bulletin.

[40]  L. Cronbach.  Coefficient alpha and the internal structure of tests , 1951 .

[41]  D. Dillman.  Mail and telephone surveys : the total design method , 1979 .

[42]  A. Stewart,et al.  The MOS short-form general health survey. Reliability and validity in a patient population. , 1988, Medical care.

[43]  Wilson H. Guertin,et al.  Introduction to modern factor analysis , 1970 .

[44]  D. Goldberg,et al.  A scaled version of the General Health Questionnaire , 1979, Psychological Medicine.

[45]  J. Ware,et al.  Measuring Components of Children's Health Status , 1979, Medical care.

[46]  Georg Rasch,et al.  Probabilistic Models for Some Intelligence and Attainment Tests , 1981, The SAGE Encyclopedia of Research Design.

[47]  R A Deyo,et al.  Reproducibility and responsiveness of health status measures. Statistics and strategies for evaluation. , 1991, Controlled clinical trials.

[48]  J. Hobart,et al.  Kurtzke scales revisited: the application of psychometric methods to clinical intuition. , 2000, Brain : a journal of neurology.